$1.4 Billion Recovered for Asbestos Victims

$28,500,000 Judgement Awarded for 8 Plaintiffs

$129,300,000 Judgement Awarded for 7 Plaintiffs

$44,600,000 Judgement Awarded for 5 Plaintiffs

$21,300,000 Judgement Awarded for 9 Plaintiffs

$2,900,000 Judgement Awarded for 1 Plaintiff

$732,400,000 Judgement Awarded for 8,431 Plaintiffs

$260,000,000 Settlement Awarded for 8,000+ Plaintiffs

$231,000,000 Settlement Awarded for 6,000+ Plaintiffs

$37,000,000 Truck Wreck Jury Verdict – Semi Truck Collision

$25,000,000 Automotive Defect/Car Accident Jury Verdict – Multiple Fatality Car Collision

$15,000,000 Personal Injury/Premises Liability Jury Verdict – Fall Resulting in Brain Injury

$32,500,000 Automotive Defect Jury Verdict – Brain Injury Due to Defective Seatbelt

$9,000,000 Malpractice Jury Verdict – Wrongful Death Suit

$5,000,000 Malpractice Jury Verdict – Montgomery Lawsuit

Why are Women with Essure Suing the Device’s Manufacturer?

Why are Women with Essure Suing the Device’s Manufacturer? Find Out About Your Potential Compensation

There are many signs that something is wrong with your Essure during implant or after removal. Women often experience severe pain, heavy menstrual bleeding, headache, fatigue and weight fluctuation.

You may be entitled to compensation for your suffering

Please fill out the form for a free case review

What is Essure?

Essure is a permanent birth control device offered as an alternative to tubal ligation. Originally manufactured by Conceptus Inc., which was later purchased by Bayer HealthCare, Essure has been promoted as an effective, non-surgical, and permanent form of birth control.

However, women having undergone the Essure implant procedure report experiencing numerous, serious, and often debilitating, side effects.

At present, more than 16,000 lawsuits have been filed against Bayer alleging that, despite having knowledge of the serious injuries caused by this device, rather than take steps to pull it from the market or provide stronger warnings, Bayer continued to promote this device as a safe and effective form of permanent birth control.

How Essure Works

Essure has been available in the U.S. since November 2002. The Essure System consists of flexible metallic coils and polyethylene (PET) fibers, which are inserted into the fallopian tubes.

Over a period of about three months, the PET fibers cause a chronic and permanent inflammatory response that causes scar tissue to form around the coils. The scar tissue creates a barrier that keeps sperm from reaching the eggs, thereby preventing conception.

Three months after Essure is implanted, women must undergo a second procedure, an Essure confirmation test, or hysterosalpingogram (HSG), to confirm that the fallopian tubes are completely blocked.

Until having received confirmation that the fallopian tubes are fully blocked, women are advised to take/use alternative forms of birth control or abstain from sexual intercourse.

Essure Injuries & Problems

Since introduced to the market in 2002, over 26,000 complaints about Essure have been reported to the FDA. Injuries reported to the FDA include, but are certainly not limited to:

Injuries caused by Essure:

Hysterectomy
Unintended/Ectopic Pregnancy
Breakage of One or Both Micro-Inserts
Migration of one or both micro-inserts
Nickel Poisoning (hair loss, rashes, metal taste in mouth, joint/muscle pain, tooth decay, etc.)
Perforation of the Uterus, Fallopian Tube(s), and/or Other Pelvic/Abdominal Organs
Abnormal/Heavy Menstrual Bleeding
Severe Abdominal/Pelvic Pain
Autoimmune Disorders
Severe Menstrual Pain

FDA Restricts the Sale and Distribution of Essure

June 2008:

Bayer is cited for making Essure implants in an unlicensed factory since at least 2005

January 2011:

Bayer is cited for using unapproved materials in the manufacturing of the Essure implants

September 2015:

In light of mounting complaints, the FDA convened a safety hearing of the Essure implants

February 2016:

Bayer was ordered to add a Black Box Warning to Essure’s Label and additional clinical trials

October 2016:

FDA issued a final guidance for content& Information to be included in Essure’s Labeling and box warning, as well as decision checklist.

April 2018:

FDA restricted sales of Essure through FDA-approved, “Patient-Doctor Discussion Checklist-Acceptance of Risk and Informed Decision Acknowledgement”

In fact, aside from the United States, Essure is no longer being sold in any other country in the world. More specifically, in February of 2017, ANVISA, the Brazilian equivalent of the USA’s FDA, suspended the importation, distribution and use of Essure in Brazil. Thereafter, Bayer voluntarily withdrew the product from Finland, the Netherlands, the United Kingdom, and Canada.

More recently, Essure was banned in Australia, which was followed by a suspension of sales in Europe, pending a safety review and investigation by the National Standards Authority of Ireland; Europe’s equivalent to the USA’s FDA.